MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Factors influencing voice function after deep brain stimulation in Parkinson’s disease

H. Jergas, T. Tsuboi, V. Stopic, D. Nakatsubo, C. Hennen, S. Maesawa, J. Einhaus, R. Saito, V. Visser-Vandewalle, M. Katsuno, M. Barbe (Cologne, Germany)

Meeting: 2023 International Congress

Abstract Number: 1696

Keywords: Deep brain stimulation (DBS), Parkinson’s

Category: Surgical Therapy: Parkinson's Disease

Objective: To assess the effect of Deep Brain Stimulation (DBS) on self-perceived changes of voice function in Parkinson’s disease (PD).

Background: To date, the effect of DBS on speech function has been assessed in many studies, indicating that DBS may improve or worsen speech function independent of the effect of motor function [1,2].

Method: We here present a dataset from a large multinational, bi-centric cohort with N = 67 (31 female) individuals (Cologne, GER N = 46; Nagoya, JAP N = 21) for the assessment of voice function by means of the Voice Handicap Index (VHI) before and after DBS. We conducted a correlation analysis to evaluate the impact of demographic factors (age, sex), disease-associated factors (difference in daily levodopa dosage prior to and after surgery [LEDD change], disease duration, mini mental status examination, PDQ-39 communication item) as well as DBS-specific factors (electrode position, local charge) on VHI change scores. Subsequently, factors with a pronounced correlation (p < .2) to change scores were included in univariate regression analysis.

Results: There was a correlation between LEDD change r(65) = -.3, p = .009, total VHI and its respective subscores (emotional, physical and functional) at Baseline change r(65) =  -.47/.24/.21/.21, p = .059/.048/.079/.079 and charge on the left hemisphere r(65) = -. -.36, p = .002.

Regression analysis indicated, that a reduction of dopaminergic medication (β = 8.01, p < 0.01), poor voice function prior to DBS (β = .36, p < 0.01), and lower charge on the left hemisphere electrode (β = -.17, p < 0.01), predict an improvement of voice function after DBS while contact position, age or disease duration do not play a significant role (Fig. 1 A, B, C).

[Figure 1]

Conclusion: The clinician can potentially adjust factors negatively influencing voice after DBS.

MDS Figure1

References: 1. Frost E, Tripoliti E, Hariz MI, Pring T, Limousin P. Self-perception of speech changes in patients with Parkinson’s disease following deep brain stimulation of the subthalamic nucleus. International Journal of Speech-Language Pathology. Oktober 2010;12(5):399–404.
2. Tanaka Y, Tsuboi T, Watanabe H, Nakatsubo D, Maesawa S, Kato S, u. a. Longitudinal Speech Change After Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease Patients: A 2-Year Prospective Study. J Parkinsons Dis. 2020;10(1):131–40.

To cite this abstract in AMA style:

H. Jergas, T. Tsuboi, V. Stopic, D. Nakatsubo, C. Hennen, S. Maesawa, J. Einhaus, R. Saito, V. Visser-Vandewalle, M. Katsuno, M. Barbe. Factors influencing voice function after deep brain stimulation in Parkinson’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/factors-influencing-voice-function-after-deep-brain-stimulation-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/factors-influencing-voice-function-after-deep-brain-stimulation-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley